ADGRG6 and cancer: In this study, whole-genome and targeted sequencing of UBCs identified recurrent ADGRG6 enhancer mutations and FRS2 amplifications, as well as high-frequency alterations in a group of angiogenesis regulators, which may significantly facilitate our understanding of molecular mechanisms underlying pathological angiogenesis in the highly vascularized cancer.